Enhanced CRAd Activity Using Enhancer Motifs Driven by a Nucleosome Positioning Sequence-Reference-Cited by-同舟云学术

Enhanced CRAd Activity Using Enhancer Motifs Driven by a Nucleosome Positioning Sequence

Published:2013-07 Issue:7 Volume:21 Page:1403-1412
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Bravo Soraya,Núñez Felipe,Cruzat Fernando,Cafferata Eduardo G,De Ferrari Giancarlo V,Montecino Martín,Podhajcer Osvaldo L

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference46 articles.

1. Gene therapy for gastric cancer: is it promising?;Sutter;World J Gastroenterol,2006

2. COX-derived prostanoid pathways in gastrointestinal cancer development and progression: Novel targets for prevention and intervention;Cathcart;Biochim Biophys Acta,2012

3. The pathobiological features of gastrointestinal cancers (Review);Yang;Oncol Lett,2012

4. Epidemiology of gastrointestinal and liver tumors;Herszényi;Eur Rev Med Pharmacol Sci,2010

5. Gene therapy developments for pancreatic cancer;Bhattacharyya;Best Pract Res Clin Gastroenterol,2006

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements and challenges in oncolytic virus therapy for gastrointestinal tumors;Biomedicine & Pharmacotherapy;2023-12

2. Hepatocellular carcinoma-targeting oncolytic adenovirus overcomes hypoxic tumor microenvironment and effectively disperses through both central and peripheral tumor regions;Scientific Reports;2018-02-02

3. A NOTCH-sensitive uPAR-regulated oncolytic adenovirus effectively suppresses pancreatic tumor growth and triggers synergistic anticancer effects with gemcitabine and nab-paclitaxel;Oncotarget;2017-02-07